Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
3.650
+0.610 (20.07%)
At close: Dec 5, 2025, 4:00 PM EST
3.648
-0.002 (-0.04%)
After-hours: Dec 5, 2025, 7:44 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Artificial Intelligence-driven DNA Biomarker Testing Technology
34.89K
Log In
Log In
Artificial Intelligence-driven DNA Biomarker Testing Technology Growth
104.45%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
34.89K
Log In
Log In
United States Growth
104.45%
Log In
Log In